OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Sensitizing cancer cells to immune checkpoint inhibitors by microbiota-mediated upregulation of HLA class I
Valentina Ferrari, Antonino Lo Cascio, Alessia Melacarne, et al.
Cancer Cell (2023) Vol. 41, Iss. 10, pp. 1717-1730.e4
Open Access | Times Cited: 18
Valentina Ferrari, Antonino Lo Cascio, Alessia Melacarne, et al.
Cancer Cell (2023) Vol. 41, Iss. 10, pp. 1717-1730.e4
Open Access | Times Cited: 18
Showing 18 citing articles:
Lactobacillus intestinalis facilitates tumor-derived CCL5 to recruit dendritic cell and suppress colorectal tumorigenesis
Yong Sun, Qiwen Wang, Yao Jiang, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 2
Yong Sun, Qiwen Wang, Yao Jiang, et al.
Gut Microbes (2025) Vol. 17, Iss. 1
Open Access | Times Cited: 2
Gut microbial metabolites in cancer therapy
Panwei Song, Zhi Peng, Xiaohuan Guo
Trends in Endocrinology and Metabolism (2024)
Closed Access | Times Cited: 7
Panwei Song, Zhi Peng, Xiaohuan Guo
Trends in Endocrinology and Metabolism (2024)
Closed Access | Times Cited: 7
Unveiling the intratumoral microbiota within cancer landscapes
Shusheng Che, Zhiyong Yan, Yugong Feng, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109893-109893
Open Access | Times Cited: 6
Shusheng Che, Zhiyong Yan, Yugong Feng, et al.
iScience (2024) Vol. 27, Iss. 6, pp. 109893-109893
Open Access | Times Cited: 6
Pharmacological induction of MHC-I expression in tumor cells revitalizes T cell anti-tumor immunity
Qian Yu, Dong Yu, Xiaobo Wang, et al.
JCI Insight (2024) Vol. 9, Iss. 17
Open Access | Times Cited: 4
Qian Yu, Dong Yu, Xiaobo Wang, et al.
JCI Insight (2024) Vol. 9, Iss. 17
Open Access | Times Cited: 4
HDAC3: A Multifaceted Modulator in Immunotherapy Sensitization
Rui Han, Yi‐Bo Luo, Jingdong Gao, et al.
Vaccines (2025) Vol. 13, Iss. 2, pp. 182-182
Open Access
Rui Han, Yi‐Bo Luo, Jingdong Gao, et al.
Vaccines (2025) Vol. 13, Iss. 2, pp. 182-182
Open Access
Adoptive cell therapy against tumor immune evasion: mechanisms, innovations, and future directions
Liqin Ruan, Lu Wang
Frontiers in Oncology (2025) Vol. 15
Open Access
Liqin Ruan, Lu Wang
Frontiers in Oncology (2025) Vol. 15
Open Access
Turning cold into hot: emerging strategies to fire up the tumor microenvironment
Kejing Ma, Lin Wang, Wenhui Li, et al.
Trends in cancer (2024)
Closed Access | Times Cited: 3
Kejing Ma, Lin Wang, Wenhui Li, et al.
Trends in cancer (2024)
Closed Access | Times Cited: 3
Optimizing abemaciclib-induced diarrhea management in patients with breast cancer: a pragmatic 2-group study using a postbiotic microbiota stabilizer
Rita De Sanctis, Paola Tiberio, Flavia Jacobs, et al.
The Oncologist (2024) Vol. 29, Iss. 9, pp. e1113-e1119
Open Access | Times Cited: 2
Rita De Sanctis, Paola Tiberio, Flavia Jacobs, et al.
The Oncologist (2024) Vol. 29, Iss. 9, pp. e1113-e1119
Open Access | Times Cited: 2
The role of the gut microbiome in modulating immunotherapy efficacy in colorectal cancer
Siyuan Zuo, Yong Huang, Junwei Zou
IUBMB Life (2024) Vol. 76, Iss. 12, pp. 1050-1057
Closed Access | Times Cited: 1
Siyuan Zuo, Yong Huang, Junwei Zou
IUBMB Life (2024) Vol. 76, Iss. 12, pp. 1050-1057
Closed Access | Times Cited: 1
The gut microbiome modulate response to immunotherapy in cancer
Shanshan Jiang, Zi‐Ran Kang, Yingxuan Chen, et al.
Science China Life Sciences (2024)
Closed Access | Times Cited: 1
Shanshan Jiang, Zi‐Ran Kang, Yingxuan Chen, et al.
Science China Life Sciences (2024)
Closed Access | Times Cited: 1
Pharmacomicrobiomics in precision cancer therapy: bench to bedside
Khanh Le Ngoc, Tran Thu Ha Pham, Tiep Khac Nguyen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Khanh Le Ngoc, Tran Thu Ha Pham, Tiep Khac Nguyen, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 1
Microbiome dynamics in immune checkpoint blockade
Chae Won Kim, Hyun-Jin Kim, Heung Kyu Lee
Trends in Endocrinology and Metabolism (2024) Vol. 35, Iss. 11, pp. 996-1005
Closed Access
Chae Won Kim, Hyun-Jin Kim, Heung Kyu Lee
Trends in Endocrinology and Metabolism (2024) Vol. 35, Iss. 11, pp. 996-1005
Closed Access
One size might fit all: Indole-3-propionic acid potentiates pan-cancer immunotherapy
Zheshun Pi, Weici Liu, Wenjun Mao
Cell Host & Microbe (2024) Vol. 32, Iss. 5, pp. 627-630
Closed Access
Zheshun Pi, Weici Liu, Wenjun Mao
Cell Host & Microbe (2024) Vol. 32, Iss. 5, pp. 627-630
Closed Access
Connexin 43 Deficiency Confers Resistance to Immunotherapy in Lung Cancer via Inhibition of the Cyclic GMP‐AMP Synthase–Stimulator of Interferon Genes Pathway
Yuan Zhang, Yu Gao, Jie Wang, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 22
Open Access
Yuan Zhang, Yu Gao, Jie Wang, et al.
Journal of Cellular and Molecular Medicine (2024) Vol. 28, Iss. 22
Open Access
Gut microbiota-mediated gut-liver axis: a breakthrough point for understanding and treating liver cancer
Chenyang Li, Chujun Cai, Chendong Wang, et al.
Clinical and Molecular Hepatology (2024)
Open Access
Chenyang Li, Chujun Cai, Chendong Wang, et al.
Clinical and Molecular Hepatology (2024)
Open Access
Beyond probiotics: postbiotics sensitize cancer cells to immune checkpoint inhibitors
Weici Liu, Zheshun Pi, Wenjun Mao
Trends in cancer (2023)
Closed Access | Times Cited: 1
Weici Liu, Zheshun Pi, Wenjun Mao
Trends in cancer (2023)
Closed Access | Times Cited: 1
I batteri intestinali aumentano l’efficacia dell'immunoterapia
Cristina Da Rold
Nature Italy (2023)
Closed Access
Cristina Da Rold
Nature Italy (2023)
Closed Access
